Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2021
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III TrialLinda G W Kerkmeijer, Veerle H Groen, Floris J Pos, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear acceleratorMariska D den Hartogh, Hans C J de Boer, Eline N de Groot-van Breugel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2020
Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-LinacD M de Muinck Keizer, L G W Kerkmeijer, T Willigenburg, et al.
Physics and Imaging in Radiation Oncology|June 9, 2025
Reconstructed dose and geometric coverage for tight margins using intrafraction re-planning on an integrated magnetic resonance imaging and linear accelerator system for prostate cancer patientsIngeborg van den Berg, Cornel Zachiu, Eline N de Groot-van Breugel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2024
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trialK Menne Guricová, F J Pos, I G Schoots, et al.
Practical Radiation Oncology|December 3, 2022
Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation TherapyFrederik R Teunissen, Thomas Willigenburg, Alison C Tree, et al.
Iscience|June 7, 2024
Human SIRT5 variants with reduced stability and activity do not cause neuropathology in miceTaolin Yuan, Surinder Kumar, Mary E Skinner, et al.
The Journal of Clinical Investigation|August 14, 2012
A metabolic prosurvival role for PML in breast cancerArkaitz Carracedo, Dror Weiss, Amy K Leliaert, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
<i>SIRT5</i> variants from patients with mitochondrial disease are associated with reduced SIRT5 stability and activity, but not with neuropathologyTaolin Yuan, Surinder Kumar, Mary Skinner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Nicolaas P A Zuithoff, Marcel van Schie, et al.
Pageof 14